Lupin rises as its arm launches Zolpidem Sublingual Tablets in the US

05 Apr 2016 Evaluate

Lupin is currently trading at Rs. 1474.30, up by 13.00 points or 0.89% from its previous closing of Rs. 1461.30 on the BSE.

The scrip opened at Rs. 1465.00 and has touched a high and low of Rs. 1478.25 and Rs. 1447.00 respectively. So far 256487 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127.00 on 06-Oct-2015 and a 52 week low of Rs. 1294.05 on 29-Mar-2016.

Last one week high and low of the scrip stood at Rs. 1502.55 and Rs. 1418.10 respectively. The current market cap of the company is Rs. 66100.52 crore.

The promoters holding in the company stood at 46.53% while Institutions and Non-Institutions held 43.56% and 9.92% respectively.

Lupin‘s US subsidiary -- Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the first product from its GAVIS pipeline, Zolpidem Sublingual Tablets, 1.75 mg & 3.5 mg to market a generic equivalent of Purdue Pharma L.P’s Intermezzo Sublingual Tablets, 1.75 mg & 3.5 mg, having received final approval from the United States Food & Drug Administration (FDA) earlier, as well as final clearance from the FTC with 180 days of exclusivity.

Zolpidem Sublingual Tablets, 1.75 mg & 3.5 mg are AB-rated generic equivalent of Purdue Pharma L.P’s Intermezzo Sublingual Tablets, 1.75 mg & 3.5 mg and is indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. Intermezzo had US sales of USD 9.46 million (IMS MAT December 2015).

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment.

Lupin Share Price

2163.15 -15.05 (-0.69%)
20-Jan-2026 11:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.00
Dr. Reddys Lab 1170.85
Cipla 1388.65
Zydus Lifesciences 883.00
Lupin 2163.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×